Jo Raskin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Tyrosine Kinase

Clinical Practice

Neoadjuvant Chemotherapy

Small Cell Lung Cancer

Top Venues

The European respiratory journal

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jo Raskin, Veerle Surmont, Alexander P W M Maat, Maha Yahia, Sjaak A Burgers, Yassin Pretzenbacher, Frederic De Ryck, Robin Cornelissen, Houke M Klomp, Ana Oliveira, Joachim Aerts, Paul Baas, Sandrine Marreaud, Jan P Van Meerbeeck, Paul E Y Van Schil
A randomised phase II study of extended pleurectomy/decortication (e-PD) preceded or followed by chemotherapy in patients (pts) with early-stage pleural mesothelioma (PM): EORTC 1205. The European respiratory journal (2024)
Jo Raskin, Veerle Surmont, Alexander P W M Maat, Maha Yahia, Sjaak A Burgers, Yassin Pretzenbacher, Frederic De Ryck, Robin Cornelissen, Houke M Klomp, Ana Oliveira, Joachim Aerts, Paul Baas, Sandrine Marreaud, Jan P Van Meerbeeck, Paul E Y Van Schil
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205. The European respiratory journal 63 (6) (2024)
Jo Raskin, Veerle Surmont, Alexander P W M Maat, Maha Yahia, Sjaak A Burgers, Yassin Pretzenbacher, Frederic De Ryck, Robin Cornelissen, Houke M Klomp, Ana Oliveira, Joachim Aerts, Paul Baas, Sandrine Marreaud, Jan P Van Meerbeeck, Paul E Y Van Schil
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205. The European respiratory journal 63 (6) (2024)
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, Jo Raskin, Joris Van Cleemput, Veerle F Surmont, Kristiaan Nackaerts, Elly Marcq, Jan P van Meerbeeck, Kevin Lamote
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma. Cancers 14 (13) (2022)
Jo Raskin, Annemiek Snoeckx, Annelies Janssens, Charlotte De Bondt, Reinier Wener, Mick van de Wiel, Jan P van Meerbeeck, Evelien L J Smits
New Implications of Patients' Sex in Today's Lung Cancer Management. Cancers 14 (14) (2022)
Sophie Rovers, Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P van Meerbeeck, Evelien L J Smits, Elly Marcq
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma. Biomedicines 10 (3) (2022)
Birgitta I Hiddinga, Jo Raskin, Annelies Janssens, Patrick Pauwels, Jan P van Meerbeeck
Recent developments in the treatment of small cell lung cancer. European respiratory review : an official journal of the European Respiratory Society 30 (161) (2021)
Xiuning Li, Hiroshi Sakai, Enriqueta Felip, Remi Veillon, Marina Chiara Garassino, Jo Raskin, Alexis B Cortot, Santiago Viteri, Julien Mazieres, Egbert F Smit, Michael Thomas, Wade T Iams, Byoung Chul Cho, Hye Ryun Kim, James Chih-Hsin Yang, Yuh-Min Chen, Jyoti D Patel, Christine M Bestvina, Keunchil Park, Frank Griesinger, Melissa Johnson, Maya Gottfried, Christian Britschgi, John Victor Heymach, Elif Sikoglu, Karin Berghoff, Karl-Maria Schumacher, Rolf Bruns, Gordon Otto, Paul K Paik
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Elien Augustus, Karen Zwaenepoel, Vasiliki Siozopoulou, Jo Raskin, Stephanie Jordaens, Geert Baggerman, Laure Sorber, Geert Roeyen, Marc Peeters, Patrick Pauwels
Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy-The Role of Liquid Biopsy in Unraveling the Puzzle. Cancers 13 (7) (2021)
Egbert F Smit, Christophe Dooms, Jo Raskin, Ernest Nadal, Lye M Tho, Xiuning Li, Julien Mazieres, Soon Hin How, Masahiro Morise, Viola W Zhu, Daniel Shao-Weng Tan, Kristina H Holmberg, Barbara Ellers-Lenz, Svenja Adrian, Sabine Brutlach, Karl M Schumacher, Niki Karachaliou, Yi-Long Wu
INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET -amplified NSCLC and first-line osimertinib resistance. Future oncology (London, England) 18 (9) (2021)
Eline Berghmans, Julie Jacobs, Christophe Deben, Christophe Hermans, Glenn Broeckx, Evelien L J Smits, Evelyne Maes, Jo Raskin, Patrick Pauwels, Geert Baggerman
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients. Cancers 12 (4) (2020)